IRIS
BELLAN, CRISTIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.063
EU - Europa 10.763
AS - Asia 5.476
SA - Sud America 815
AF - Africa 304
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 7
Totale 29.448
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.868
GB - Regno Unito 2.522
RU - Federazione Russa 2.004
CN - Cina 1.919
IT - Italia 1.767
SG - Singapore 1.620
IE - Irlanda 1.230
DE - Germania 733
BR - Brasile 696
SE - Svezia 657
UA - Ucraina 633
FR - Francia 551
VN - Vietnam 515
HK - Hong Kong 473
FI - Finlandia 282
KR - Corea 262
IN - India 161
ZA - Sudafrica 157
BD - Bangladesh 148
CA - Canada 114
TR - Turchia 104
NL - Olanda 63
PL - Polonia 63
ES - Italia 61
BE - Belgio 50
IQ - Iraq 50
AR - Argentina 47
MX - Messico 44
AT - Austria 39
JP - Giappone 32
PK - Pakistan 30
CI - Costa d'Avorio 29
KE - Kenya 29
NG - Nigeria 29
ID - Indonesia 26
EC - Ecuador 20
SA - Arabia Saudita 20
MA - Marocco 18
VE - Venezuela 17
CZ - Repubblica Ceca 15
AU - Australia 14
UZ - Uzbekistan 14
CL - Cile 13
GR - Grecia 11
NP - Nepal 11
AZ - Azerbaigian 10
CH - Svizzera 10
IL - Israele 10
LT - Lituania 10
CO - Colombia 9
RO - Romania 9
TN - Tunisia 9
DO - Repubblica Dominicana 8
IR - Iran 8
AL - Albania 7
EU - Europa 7
JM - Giamaica 7
JO - Giordania 7
MY - Malesia 7
PA - Panama 7
PT - Portogallo 7
UG - Uganda 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
LV - Lettonia 6
KG - Kirghizistan 5
PE - Perù 5
PH - Filippine 5
TT - Trinidad e Tobago 5
AO - Angola 4
BG - Bulgaria 4
CR - Costa Rica 4
KZ - Kazakistan 4
MT - Malta 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
UY - Uruguay 4
AM - Armenia 3
EE - Estonia 3
GT - Guatemala 3
NO - Norvegia 3
OM - Oman 3
PS - Palestinian Territory 3
PY - Paraguay 3
RS - Serbia 3
SI - Slovenia 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
HR - Croazia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
MM - Myanmar 2
PW - Palau 2
QA - Qatar 2
Totale 29.427
Salva come PNG Salva come JPEG
Città #
Southend 2.290
Dallas 1.239
Dublin 1.192
Fairfield 1.037
Singapore 948
Ashburn 903
Houston 711
Chandler 641
Santa Clara 585
Moscow 582
San Jose 537
Jacksonville 536
Beijing 521
Woodbridge 497
Hong Kong 453
Milan 420
Siena 396
Wilmington 392
Seattle 356
Ann Arbor 346
Hefei 316
Cambridge 312
Seoul 259
Princeton 241
New York 224
Menlo Park 216
Los Angeles 206
Council Bluffs 196
Nanjing 185
The Dalles 177
Rome 159
Ho Chi Minh City 153
Johannesburg 143
Munich 140
Lauterbourg 130
Helsinki 101
Hanoi 95
Florence 89
Boardman 86
Buffalo 81
Dong Ket 77
Dearborn 76
Nanchang 74
São Paulo 74
Shanghai 73
San Mateo 72
Izmir 67
San Diego 61
Turku 55
Warsaw 51
Brussels 49
Chicago 47
Orem 46
Málaga 44
Figino 43
London 41
Columbus 40
Montreal 40
Shenyang 38
Düsseldorf 37
Bengaluru 36
Tianjin 34
Frankfurt am Main 33
Turin 33
Fremont 32
Denver 31
Lappeenranta 31
Toronto 31
Redondo Beach 30
Abidjan 29
Atlanta 29
Bologna 29
Abuja 28
Hebei 28
San Francisco 28
Jiaxing 27
Brooklyn 26
Changsha 26
Phoenix 26
Chennai 25
Kunming 24
Tokyo 24
Guangzhou 23
Naples 23
Sezze 23
Belo Horizonte 21
Manchester 21
Vienna 21
Amsterdam 20
Stockholm 19
Da Nang 18
Falls Church 18
Haiphong 18
Jinan 18
Mexico City 18
Nuremberg 18
Baghdad 17
Norwalk 17
Poplar 17
Rio de Janeiro 17
Totale 20.183
Salva come PNG Salva come JPEG
Nome #
Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach 569
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 402
Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: A pre-clinical assessment 360
Omic Approach in Non-Smoker Female with Lung Squamous Cell Carcinoma Pinpoints to Germline Susceptibility and Personalized Medicine 354
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output 353
B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression 350
Analisi del riarrangiamento e delle mutazioni del gene VH delle immunoglobuline nelle cellule B monocitoidi M-IRTA-1 positive. 343
Frequent Traces of EBV Infection in Hodgkin and non-Hodgkin Lymphomas Classified as EBV-negative by Routine Methods: Expanding the Landscape of EBV-related Lymphomas 342
Analysis of the IgVH genes in T cell-mediated and antibody-mediated rejection of the kidney graft. 334
Unveiling another missing piece in EBV-driven lymphomagenesis: EBV-encoded microRNAs expression in EBER-negative Burkitt lymphoma cases 330
Clonality analysis of immunoglobulin gene rearrangement by next-generation sequencing in endemic burkitt lymphoma suggests antigen drive activation of bcr as opposed to sporadic burkitt lymphoma 320
Role of Epstein-Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature 320
Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma 319
Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors. 310
Langerhans cell sarcoma following marginal zone lymphoma: expanding the knowledge on mature B cell plasticity 306
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 305
VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues. 304
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications 301
Preferential usage of specific immunoglobulin heavy chain variable region genes with unmutated profile and advanced stage at presentation are common features in patients with chronic lymphocytic leukemia from Senegal 298
Alteration of microRNAs regulated by c_Myc in Burkitt lymphoma 291
Identification of single-nucleotide variants by high-throughput RNA sequencing in endemic Burkitt Lymphoma 287
Burkitt lymphoma versus diffuse large B-cell lymphoma: A practical approach 281
EBV reactivation influences clonal evolution in HHV8 related lymphoprolipherative disorders? 275
Cellular kinetic differences between Hodgkin's and anaplastic large cell lymphomas: relation to the expression of p34cdc2 and cyclin B-1 271
CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation 270
Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas 262
EBV-Bart-6-3p induces cell proliferation and escape of immunosurveillance in BL cell lines and primary tumours 261
Cdk9/Cyclin T1 complex: a key player during the activation/differentiation process of normal lymphoid B cells 260
Cdk9 regulates neural differentiation and its expression correlates with the differentiation grade of neuroblastoma and PNET tumors 260
Anaplastic large cell lymphomas and Hodgkin's disease: distinctive growth features and expression of p34cdc2 /cyclin B-1 258
HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas 256
Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes 255
Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas? 246
A Multidisciplinary Approach to Improve the Management of Immune-Checkpoint Inhibitor-Related Pneumonitis 245
Burkitt’s lymphoma: new insights into molecular pathogenesis 245
Gene expression analysis uncovers similarty and differences among Burkitt lymphoma subtypes 243
Analysis of rearrangement and Vh gene mutations and correlation with the expression of M-IRTA 1 in monocytoid B cells of toxoplasmic lymphadenitis. 238
PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach 237
Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in anti-apoptotic and chromatin-remodeling genes. 236
Anaplastic large cell lymphomas and Hodkin’s disease: distinctive growth features and expression of p34cdc2/cyclin B-1 232
Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia 231
MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation 230
Activation of MyoD-dependent transcription by cdk9/cyclin T2 229
The role of the Cdk9/Cyclin T1 complex in T cell differentiation 226
Cdk9, a member of the cdc2-like family of kinases, binds to gp130, the receptor of the IL-6 family of cytokines 225
Oct-4 is highly expressed in stem/ progenitor cells and in primordial follicles of the fetal human ovary 221
Immunoglobulin gene rearrangement analysis in composite Hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells? 219
Altered expression of miRNAs in c-Myc negative Burkitt lymphoma cases 218
CDK9/Cyclin T expression in reactive lymph nodes and malignant lymphomas. 217
Analysis of primary cilium expression and hedgehog pathway activation in mesothelioma throws back its complex biology 214
FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. 214
Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin 213
Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis 211
EBV-Bart-6-3p induces cell proliferation and escape of immunosurveillance in BL cell lines and primary tumours 208
CDK9/Cyclin T expression in reactive lymph nodes and malignant lymphomas. 207
DNMT over-expression based on microRNA modulation in HIV-related aggressive B-cell lymphomas 207
Lymphoepithelial-like carcinoma of the parotid gland: a case report and a brief review of the western literature 206
Cell growth and death in malignant lymphomas. A quantitative analysis. 205
Are periodontitis and psoriasis associated? A pre-clinical murine model 203
Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms 201
Mutation of PFN1 gene in an early onset, polyostotic Paget-like disease 200
The Personalized Inherited Signature Predisposing to Non-Small-Cell Lung Cancer in Non-Smokers 199
Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo 199
Pseudolymphoma of the kidney associated with high-grade bladder urothelial carcinoma 193
CD34+ cord blood cell-transplanted Rag2-/- gamma(c)-/- mice as a model for Epstein-Barr virus infection 191
Expression of p34(cdc2) and cyclins A and B compared to other proliferative features of non-Hodgkin's lymphomas: a multivariate cluster analysis 191
Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation 191
MicroRNA expression profile identifies a distinct molecular signature between MYC translocation-positive and negative Burkitt lymphoma cases 190
Retinoblastoma gene family expression in lymphoid tissues 189
Tumor-Suppressor Genes as Diagnostic Tools 189
IRTA1+ monocytoid B cells in reactive lymphadenitis show a unique topographic distribution and immunophenotype and a peculiar usage and mutational pattern of IgVH genes. 189
Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation 187
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations 185
Role of EBV in microRNA dysregulation in Burkitt lymphoma 185
Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis 184
Cell kinetics and cell cycle regulation in lymphomas. 184
Expression of cell cycle-regulated proteins pRB2/p130, p107, E2F4, p27, and pCNA in salivary gland tumors: prognostic and diagnostic implications. 183
Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes 181
The XLMR gene ACSL4 plays a role in dendritic spine architecture 180
P53 mutation in breast cancer, correlation with cell kinetics and cell of origin 179
First-line pharmacotherapies and survival among patients diagnosed with non-resectable NSCLC: a real-life setting study with gender prospective 179
Pathologic aspects of AIDS malignancies 178
Renal sinus pseudolymphoma in a patient with multiple carcinomas: a case report and a brief review of the literature. 176
Physical interaction between pRb and cdk9/cyclin T2 complex 175
Correction: P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma (Cell Death & Disease, (2020), 11, 9, (748), 10.1038/s41419-020-02940-w) 175
Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications (Virchows Archiv, (2020), 477, 1, (143-150), 10.1007/s00428-019-02712-8) 174
TAVR and Dialysis Are a Challenging Combination. A Case Report and Systematic Review of Literature 174
EBV-Bart-6-3p induces cell proliferation and escape of immunosurveillance in BL cell lines and primary tumours 173
Expression of p34(cdc2) and cyclin B-1 in Hodgkin's disease and anaplastic large cell lymphomas 172
Sarcoid Nodule or Lung Cancer? A High-Resolution Computed Tomography-Based Retrospective Study of Pulmonary Nodules in Patients with Sarcoidosis 169
P53 mutation in breast cancer correlation with cell kinetics and cell of origin 168
Predictive prognostic factors of surgically treated intra-pulmonary mettstases from colorectal carcinomas: a 30 years retrospective analysis 167
Linking regional administrative data with an hospital pathology registry in Italy to describe first-line pharmacotherapy of non-resectable non-small cell lung cancer in 2009-2017 167
Mesothelioma malignancy and the microenvironment: Molecular mechanisms 167
The interaction between HIV-1 Tat and pRb2/p130: a possibile mechanisms in the pathogenesis of AIDS-related neoplasms. 164
null 164
Tumor microenvironment of Burkitt lymphoma: different immune signatures with different clinical behavior 163
Comparison of two mechanical disaggregation methods of fresh lung tissues for extraction of high-quality RNA 161
null 161
Geographic variation and environmental conditions as cofactors in Chlamydia psittaci association with ocular adnexal lymphomas: a comparison between Italian and African samples 160
Totale 23.390
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.558
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.819 118 210 112 204 103 65 86 127 74 193 140 387
2022/20232.448 145 211 338 336 243 477 50 214 236 66 80 52
2023/20241.910 77 48 194 69 58 576 627 27 30 55 23 126
2024/20254.006 98 217 383 206 559 213 86 222 336 161 437 1.088
2025/20269.991 739 1.297 1.034 1.190 1.880 359 1.099 316 334 525 340 878
2026/2027164 164 0 0 0 0 0 0 0 0 0 0 0
Totale 29.742